Conference Coverage
Conference Coverage
Lower hydroxychloroquine dose for lupus tied to hospitalizations for flares
Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose,...
Conference Coverage
Statins boost glycemia slightly, but CVD benefits prevail
Meta-analysis of 23 trials confirmed statins raise glycemia and can trigger diabetes, but the effect pales compared with their CVD prevention.
Conference Coverage
Steroids and G-CSF improve 90-day survival in severe alcoholic hepatitis
In addition to its superior results on the primary endpoint of 90-day survival, combination therapy was associated with significantly better...
Conference Coverage
Remibrutinib safe for Sjögren’s in phase 2
Results show the Bruton tyrosine kinase inhibitor has potential to become the first effective oral disease-modifying therapy for Sjögren syndrome...
Conference Coverage
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
Conference Coverage
Rituximab ‘a reasonable alternative to cyclophosphamide’ to improve ILD-CTD
A clinical trial found that rituximab and cyclophosphamide had similar outcomes for interstitial lung disease associated with connective tissue...
Conference Coverage
How AI is, or will soon be, relevant in radiation oncology
Radiation oncologists at ASTRO 2022 discuss practical applications of AI, and new research findings.
Conference Coverage
Clinical signs differ between children and adults with vasculitis
Many pediatric rheumatologists believe kids with vasculitis are like small adults and should be treated similarly, but Dr. Jessica Bloom said the...
Guidelines
First recommendations for cancer screening in myositis issued
The guideline, based on data from a systematic review and meta-analysis and on consensus from an international team of experts and patients,...
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
Latest News
Breaking the itch-scratch cycle with mindfulness
Mindful breathing can help interrupt the itch-scratch cycle and relieve pain, stress, and distress often experienced by children, teens, and...